These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 25331845

  • 1. Bilateral or unilateral stimulation for baroreflex activation therapy.
    de Leeuw PW, Alnima T, Lovett E, Sica D, Bisognano J, Haller H, Kroon AA.
    Hypertension; 2015 Jan; 65(1):187-92. PubMed ID: 25331845
    [Abstract] [Full Text] [Related]

  • 2. Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant Hypertension.
    Wallbach M, Lehnig LY, Schroer C, Lüders S, Böhning E, Müller GA, Wachter R, Koziolek MJ.
    Hypertension; 2016 Apr; 67(4):701-9. PubMed ID: 26902491
    [Abstract] [Full Text] [Related]

  • 3. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.
    Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA.
    J Am Coll Cardiol; 2011 Aug 09; 58(7):765-73. PubMed ID: 21816315
    [Abstract] [Full Text] [Related]

  • 4. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
    Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD.
    J Am Soc Hypertens; 2012 Aug 09; 6(2):152-8. PubMed ID: 22341199
    [Abstract] [Full Text] [Related]

  • 5. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.
    Alnima T, de Leeuw PW, Tan FE, Kroon AA, Rheos Pivotal Trial Investigators.
    Hypertension; 2013 Jun 09; 61(6):1334-9. PubMed ID: 23589562
    [Abstract] [Full Text] [Related]

  • 6. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T, Goedhart EJ, Seelen R, van der Grinten CP, de Leeuw PW, Kroon AA.
    Hypertension; 2015 Jun 09; 65(6):1217-22. PubMed ID: 25941348
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Electrical carotid baroreceptor stimulation.
    Schmidli J, von Allmen RS, Mohaupt MG.
    Wien Med Wochenschr; 2014 Dec 09; 164(23-24):508-14. PubMed ID: 25411011
    [Abstract] [Full Text] [Related]

  • 9. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.
    Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, Cates AW, Lovett EG, Haller H.
    J Am Soc Hypertens; 2012 Dec 09; 6(4):270-6. PubMed ID: 22694986
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.
    Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, Schmidli J, Allemann Y, Delacrétaz E.
    Hypertension; 2009 Sep 09; 54(3):530-6. PubMed ID: 19620513
    [Abstract] [Full Text] [Related]

  • 11. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.
    Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichlmaier AM, Luft FC, Jordan J.
    Hypertension; 2010 Mar 09; 55(3):619-26. PubMed ID: 20101001
    [Abstract] [Full Text] [Related]

  • 12. Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review.
    Courand PY, Feugier P, Workineh S, Harbaoui B, Bricca G, Lantelme P.
    Arch Cardiovasc Dis; 2014 Dec 09; 107(12):690-6. PubMed ID: 25445751
    [Abstract] [Full Text] [Related]

  • 13. [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].
    Wallbach M, Koziolek MJ, Wachter R.
    Internist (Berl); 2018 Oct 09; 59(10):1011-1020. PubMed ID: 30182192
    [Abstract] [Full Text] [Related]

  • 14. An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.
    Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim MK, Lovett EG, Schafer JE, de Leeuw PW.
    J Am Soc Hypertens; 2017 Feb 09; 11(2):81-91. PubMed ID: 28065708
    [Abstract] [Full Text] [Related]

  • 15. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
    Dell'Oro R, Gronda E, Seravalle G, Costantino G, Alberti L, Baronio B, Staine T, Vanoli E, Mancia G, Grassi G.
    J Hypertens; 2017 Dec 09; 35(12):2532-2536. PubMed ID: 28816745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up.
    de Leeuw PW, Bisognano JD, Bakris GL, Nadim MK, Haller H, Kroon AA, DEBuT-HT and Rheos Trial Investigators.
    Hypertension; 2017 May 09; 69(5):836-843. PubMed ID: 28320856
    [Abstract] [Full Text] [Related]

  • 19. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.
    Illig KA, Levy M, Sanchez L, Trachiotis GD, Shanley C, Irwin E, Pertile T, Kieval R, Cody R.
    J Vasc Surg; 2006 Dec 09; 44(6):1213-1218. PubMed ID: 17145423
    [Abstract] [Full Text] [Related]

  • 20. [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].
    Koziolek M, Beige J, Wallbach M, Zenker D, Henning G, Halbach M, Mader N, Mahfoud F, Schlieper G, Schwenger V, Hausberg M, Börgel J, Lodde M, van der Giet M, Müller-Ehmsen J, Passauer J, Parmentier S, Lüders S, Krämer BK, Büttner S, Limbourg F, Jordan J, Vonend O, Predel HG, Reuter H.
    Internist (Berl); 2017 Oct 09; 58(10):1114-1123. PubMed ID: 28835975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.